BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8423021)

  • 1. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas.
    Tsao SW; Mok CH; Knapp RC; Oike K; Muto MG; Welch WR; Goodman HM; Sheets EE; Berkowitz RS; Lau CC
    Gynecol Oncol; 1993 Jan; 48(1):5-10. PubMed ID: 8423021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
    Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced ovarian carcinoma: molecular evidence of unifocal origin.
    Li S; Han H; Resnik E; Carcangiu ML; Schwartz PE; Yang-Feng TL
    Gynecol Oncol; 1993 Oct; 51(1):21-5. PubMed ID: 8244169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
    Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas.
    Park TW; Felix JC; Wright TC
    Cancer Res; 1995 Nov; 55(21):4793-6. PubMed ID: 7585507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allelic losses of tumor suppressor gene on chromosome 17 in ovarian cancer].
    Sakamoto T; Ogino M; Yamamoto T; Mori H; Okinaga S; Sonoda T; Ueda K; Obi S; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):457-63. PubMed ID: 8496636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors.
    Rodabaugh KJ; Blanchard G; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Cancer Res; 1995 May; 55(10):2169-72. PubMed ID: 7743519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.
    Bandera CA; Muto MG; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jul; 16(26):3455-9. PubMed ID: 9692553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.
    Kupryjanczyk J; Thor AD; Beauchamp R; Poremba C; Scully RE; Yandell DW
    Mod Pathol; 1996 Mar; 9(3):166-73. PubMed ID: 8685209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
    Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
    IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unifocal origin of advanced human epithelial ovarian cancers.
    Mok CH; Tsao SW; Knapp RC; Fishbaugh PM; Lau CC
    Cancer Res; 1992 Sep; 52(18):5119-22. PubMed ID: 1516069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
    Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.